FDA Label for Lmx5
View Indications, Usage & Precautions
Lmx5 Product Label
The following document was submitted to the FDA by the labeler of this product Ferndale Laboratories, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient
Lidocaine 5% w/w
Purpose
Local anesthetic
Uses
temporarily relieves pain and itching due to anorectal disorders
When Using This Product
- avoid contact with eyes
- do not exceed recommended dosage unless directed by a doctor
Stop Use And Ask A Doctor If
- rectal bleeding occurs
- condition worsens or does not improve within 7 days
- allergic reaction occurs
- redness, irritation, swelling, pain or other symptoms begin or increase
- symptoms clear up and return within a few days
Keep Out Of Reach Of Children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- When practical, clean area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or soft cloth before applying.
- Adults and Children 12 years and older: Apply to the affected area up to 6 times a day.
- Children under 12 years of age: Consult a doctor.
Other Information
Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].
Inactive Ingredients
benzyl alcohol, carbomer 940, chloesterol, hydrogenated lecithin, isopropyl myristate, polysorbate 80, propylene glycol, purified water, trolamine, and vitamin E acetate
Package Label
Manufactured for Ferndale Healthcare Inc.
Ferndale, MI 48220 U.S.A.
Toll free (888) 548-0900
www.ferndalehealthcare.com
L.M.X.5® is a registered trademark of Ferndale, IP Inc.
30 gram NDC 0496-0883-30
Back Panel
Front Panel
* Please review the disclaimer below.